Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2012
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302597 Novel p2x7r antagonists and their use
11/29/2012US20120302596 Azaindoles having serotonin receptor affinity
11/29/2012US20120302595 Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
11/29/2012US20120302593 Use of at Least One Isoquinoline Compound of Formula I, Pharmaceutical Composition for Treating or Preventing Neurodegenerative Diseases and Method for Treating or Preventing Neurodegenerative Diseases
11/29/2012US20120302592 Topiramate plus naltrexone for the treatment of addictive disorders
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302590 Methods and compositions to prevent addiction
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302583 New Compounds I
11/29/2012US20120302581 Methods and Compositions for the Treatment of RAS Associated Disorders
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302574 Methods of Preventing and Reducing the Severity of Stress-Associated Conditions
11/29/2012US20120302573 Methods of inhibiting pro matrix metalloproteinase activation
11/29/2012US20120302569 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012US20120302568 Sigma ligands for use in the prevention and/or treatment of post-operative pain
11/29/2012US20120302564 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
11/29/2012US20120302560 Novel Benzoic Pyrrolopyridine Derivatives
11/29/2012US20120302558 Oxazine derivatives and their use in the treatment of neurological disorders
11/29/2012US20120302553 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/29/2012US20120302551 Thiolactams and uses thereof
11/29/2012US20120302549 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
11/29/2012US20120302548 2-arylimidazole derivatives as pde10a enzyme inhibitors
11/29/2012US20120302546 Novel sulfamides exhibiting neuroprotective action and methods for use thereof
11/29/2012US20120302543 Compounds for the Treatment of Neurological Disorders
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302535 Progesterone treatment for improving sleep quality
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120302528 Bioabsorbable polymer compositions exhibiting enhanced crystallization and hydrolysis rates
11/29/2012US20120302526 Methods for treating post-traumatic stress disorder
11/29/2012US20120302504 Method Of Reducing Injury To Mammalian Cells
11/29/2012US20120302498 Insulin like peptides
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120302491 Modulation of estrogen receptor-related receptor gamma (err gamma) and uses therefor
11/29/2012US20120301560 Compositions comprising andrographis paniculata extracts combined with ginkgo biloba extracts complexed with phospholipids, and their use
11/29/2012US20120301551 Compounds and compositions for treating neuronal death or neurological dysfunction
11/29/2012US20120301547 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof
11/29/2012US20120301542 Extended release formulations of rasagiline and uses thereof
11/29/2012US20120301512 Tetrary Gene Delivery System for Gene Therapy and Methods of Its Use
11/29/2012US20120301496 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/29/2012US20120301473 Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
11/29/2012US20120301463 Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
11/29/2012US20120301446 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders
11/29/2012US20120301440 Methods and materials for increasing potency of cells
11/29/2012US20120301437 Technologies, Methods, and Products of Small Molecule Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells
11/29/2012US20120301403 Polyethylene glycolated superoxide dismutase mimetics
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012CA2840336A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012CA2837431A1 Autism improving agent and autism improving tea
11/29/2012CA2837312A1 Metabotropic glutamate receptor 5 modulators and methods of use thereof
11/29/2012CA2837199A1 Inhibitors of lrrk2 kinase activity
11/29/2012CA2836612A1 Antagonists of cb1 receptor
11/29/2012CA2836538A1 Clozapine immunoassay
11/29/2012CA2836503A1 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
11/29/2012CA2836483A1 Neuronal progenitor cells and uses
11/29/2012CA2836364A1 Erk inhibitors for use in treating spinal muscular atrophy
11/29/2012CA2833099A1 Cannabinoids for use in the treatment of neuropathic pain
11/29/2012CA2832605A1 Pyridine-and pyrazine derivatives
11/28/2012EP2527369A2 Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
11/28/2012EP2527366A1 Monoclonal anti beta amyloid antibody
11/28/2012EP2527340A1 Piperazine compound having a pgds inhibitory effect
11/28/2012EP2527337A1 Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
11/28/2012EP2527328A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2527006A1 Quetiapine Formulation Having a Controlled-Release Coating
11/28/2012EP2526956A1 A chinese medicine composition and preparation method and use thereof
11/28/2012EP2526949A1 Agents for treating migraine
11/28/2012EP2526947A1 Use of at least one isoquinoline compound of formula i, pharmaceutical composition for treating or preventing neurodegenerative diseases and method for treating or preventing neurodegenerative diseases
11/28/2012EP2526944A1 Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
11/28/2012EP2526098A1 Nitrogen-containing heteroaryl derivatives
11/28/2012EP2526097A1 Pyrazine derivatives
11/28/2012EP2526093A2 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012EP2525823A1 Delivery system for diagnostic and therapeutic agents
11/28/2012EP2525795A1 Methods and compositions for improved nerve conduction velocity
11/28/2012EP2525791A2 Special composition for the use thereof as a drug
11/28/2012EP2463368A9 Humanized anti-amyloid-b oligomer antibody
11/28/2012CN202552301U Sleep-aiding nerve-calming hat
11/28/2012CN102803268A Histamine H3 inverse agonists and antagonists and methods of use thereof
11/28/2012CN102803266A Purine compounds
11/28/2012CN102803263A Purine compounds used as cb2 agonists
11/28/2012CN102803261A Novel substituted bicyclic triazole derivatives as gamma secretase modulators
11/28/2012CN102803253A 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
11/28/2012CN102803252A Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
11/28/2012CN102803247A Novel fumarate salts of a histamine H3 receptor antagonist
11/28/2012CN102803224A Novel azabicyclohexanes
11/28/2012CN102803210A Azetidinyl diamides as monoacylglycerol lipase inhibitors
11/28/2012CN102802731A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102802730A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102802643A Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone
11/28/2012CN102802632A Pharmaceutical composition comprising a pyrimidineone derivative
11/28/2012CN102802631A Dosing regimen associated with long-acting injectable paliperidone esters
11/28/2012CN102802630A Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
11/28/2012CN102802620A Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
11/28/2012CN102796705A Dac hyp compositions and methods
11/28/2012CN102796179A Template - fixed peptidomimetics with antimicrobial activity
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 1833